Site Search
Professionals 639 results
Capabilities 84 results
Industry
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities.
Experience 493 results
Experience
|August 19, 2025
Winston advised Ellipsis U.S. Onshore Holdings LLC, a portfolio company of the Westlawn Group, in connection with the acquisition of high-quality, non-operated working interests in the Permian Basin of Texas and New Mexico—adding approximately 4,000 barrels of oil equivalent per day in net production and over 600 gross remaining drilling locations. This strategic transaction strengthens Ellipsis’ Delaware Basin footprint and supports its strategy of scaling through high-margin, low-cost assets.
Experience
|August 12, 2025
US$2B Roper Technologies, Inc. Senior Notes Offering
Winston & Strawn LLP served as underwriters' counsel to BofA Securities, J.P. Morgan, and Wells Fargo Securities, as joint book-running managers, in connection with the registered public offering by Roper Technologies, Inc. of US$2B of senior notes, comprised of US$500M of its 4.250% senior notes due 2028, US$500M of its 4.450% senior notes due 2030 and US$1B of its 5.100% senior notes due 2035.
Experience
|July 17, 2025
D. Boral Capital Closes US$15M Robot Consulting IPO
Winston & Strawn LLP represented D. Boral Capital LLC and Craft Capital Management LLC in connection with the US$15M initial public offering of American Depositary Shares (ADSs) of Robot Consulting Co., Ltd. The offering consisted of 3,750,000 ADSs priced at $4.00 per ADS, and the company’s ADSs began trading on the Nasdaq Capital Market under the ticker symbol “LAWR” on July 17, 2025.
Insights & News 7,926 results
Sponsorship
|October 19, 2025
Winston & Strawn Sponsors The 2025 National Summit for Middle Market Funds
Winston & Strawn is proud to be an elite sponsor of The 2025 National Summit for Middle Market Funds, the premier event for lower middle market networking and fundraising.
Seminar/CLE
|September 18, 2025
Winston Hosts New York Financial Services Symposium
Winston’s Financial Services Industry Group is pleased to host our inaugural Financial Services Symposium in our New York office on Thursday, September 18, 2025. This event will include a half-day of programming led by top industry thought leaders. Below you will find details about each panel.
Sponsorship
|September 18, 2025
Winston & Strawn Sponsors 21st Annual Boardroom Summit
Winston & Strawn is sponsoring the upcoming 21stAnnual Boardroom Summit & Board Committee Peer Exchange. This unique event will bring industry leading public company directors to discuss current trends, including shareholder activism, CEO succession strategies, and uses of AI in the boardroom.
Other Results 122 results
Site Content
Also known as maritime cabotage laws, U.S. coastwise laws reserve U.S. domestic maritime trade to qualified U.S. registered (referred to as “U.S.-flag” vessels). These laws are also commonly referred to as the Jones Act. One of these coastwise laws, the Passenger Vessel Services Act, reserves the transportation of passengers between U.S. ports, or points, to qualified U.S.-flag vessels.
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.